Whether you're considering topical serums or injectable GHK-Cu protocols , you'll find the safety information you need here
In a pool of Study 1 and 2, hair loss was reported more frequently in female than male patients in the ZEPBOUND (7.1% female versus 0.5% male) and placebo (1.3% female versus 0% male) treatment groups
This is the standard trial design for injectable peptides
For general maintenance, high-quality OTC brands with transparent ingredient disclosure and third-party COA are appropriate
These include neuroprotective benefits, mitigating drug toxicity, anti-aging benefits, analgesic effects, and treatment of metabolic disease [21, 22, 23, 24]